Literature DB >> 14528109

Misinterpretation of a Calvert-derived formula leading to carboplatin overdose in two children.

Robert I Liem1, Meghan A Higman, Allen R Chen, Robert J Arceci.   

Abstract

Carboplatin is currently recommended to be dosed according to renal function. In adults, dosing by the Calvert formula is based on evidence that carboplatin clearance closely parallels glomerular filtration rate. Several studies have attempted to validate the Calvert formula and its derivations in pediatrics, but no final consensus has been achieved. As a result, different versions of the original formula exist in the pediatric literature. Other factors may also contribute to confusion when applying the formula to young patients, including the manner in which renal function is measured and reported. We describe how misinterpretation of the Calvert formula resulted in carboplatin overdosing in 2 pediatric patients with high-risk neuroblastoma undergoing peripheral blood stem cell transplantation. Measures to avoid such errors have been instituted.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14528109     DOI: 10.1097/00043426-200310000-00017

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  3 in total

1.  Comparison of two methods for carboplatin dosing in children with retinoblastoma.

Authors:  Steven Allen; Matthew W Wilson; Amy Watkins; Catherine Billups; Ibrahim Qaddoumi; Barrett H Haik; Carlos Rodriguez-Galindo
Journal:  Pediatr Blood Cancer       Date:  2010-07-15       Impact factor: 3.167

2.  Characteristics of medication errors with parenteral cytotoxic drugs.

Authors:  A Fyhr; R Akselsson
Journal:  Eur J Cancer Care (Engl)       Date:  2012-02-16       Impact factor: 2.520

3.  Estimation of renal function and its potential impact on carboplatin dosing in children with cancer.

Authors:  G Chinnaswamy; M Cole; A V Boddy; M Keir; L Price; A Parry; M English; G J Veal
Journal:  Br J Cancer       Date:  2008-09-16       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.